ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 45 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $131,000 | +84.5% | 16,000 | 0.0% | 0.02% | +84.6% |
| Q2 2017 | $71,000 | -20.2% | 16,000 | 0.0% | 0.01% | -23.5% |
| Q1 2017 | $89,000 | +39.1% | 16,000 | 0.0% | 0.02% | +30.8% |
| Q4 2016 | $64,000 | -42.9% | 16,000 | 0.0% | 0.01% | -43.5% |
| Q3 2016 | $112,000 | -13.8% | 16,000 | 0.0% | 0.02% | -17.9% |
| Q2 2016 | $130,000 | -13.9% | 16,000 | 0.0% | 0.03% | -12.5% |
| Q1 2016 | $151,000 | -21.8% | 16,000 | 0.0% | 0.03% | -20.0% |
| Q4 2015 | $193,000 | +0.5% | 16,000 | 0.0% | 0.04% | -4.8% |
| Q3 2015 | $192,000 | -34.5% | 16,000 | 0.0% | 0.04% | -26.3% |
| Q2 2015 | $293,000 | – | 16,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |